You Searched For "gilead remdesivir" and got 20 results
Sort By:
1 min read
Batches of the COVID-19 treatment drug Remdesivir were recalled after glass particles were found in some vials
Biopharmaceutical company Gilead Sciences announced that two lots of Remdesivir are being recalled …
Cheryl Teh
2 mins read
Alexandria Ocasio-Cortez says it's 'absolutely wild' that senators can trade stocks after Rand Paul discloses controversial Gilead purchase
The politician said members of Congress should not be able to trade stocks after Rand Paul disclose…
Harry Robertson
2 mins read
Gilead rises after pricing its coronavirus-fighting drug remdesivir
"We believe that pricing remdesivir well below value is the right and responsible thing to do," sai…
Carmen Reinicke
2 mins read
Cipla signs licensing agreement with Gilead to manufacture and sell antiviral drug remdesivir
Leading pharmaceutical company Cipla on Wednesday announced it has signed a non-exclusive licensing…
2 mins read
FDA warns against co-administration of remdesivir with CQ or HCQ for COVID-19 patients
Following an evaluation of the emergency use authorization criteria and scientific evidence a…
PTI
2 mins read
Remdesivir linked to reduced risk of death in severe Covid-19 patients
This is an important finding that requires confirmation in prospective clinical trials, Gilead s…
2 mins read
Gilead sold $873 million worth of its antiviral COVID-19 treatment even though data on its success remains mixed
Gilead posted its first numbers detailing how much money the pharmaceutical company has made throug…
Allana Akhtar
2 mins read
The first approved COVID-19 drug is far from 'amazing'
These are Business Insider's biggest healthcare stories for October 26.
Lydia Ramsey Pflanzer
4 mins read
What it'll take to get a vaccine to Americans
These are the top stories written by Business Insider's healthcare team for the week ending October…
Lydia Ramsey Pflanzer
2 mins read
Gilead's remdesivir just got the first FDA approval to be used as a treatment for coronavirus patients
Gilead Sciences just received approval from the US Food and Drug Administration to use its antivira…
Allana Akhtar
2 mins read
See the pitch deck a healthcare startup founded by 2 ex-Googlers used to raise $47 million
These are Business Insider's biggest healthcare stories for October 19.
Lydia Ramsey Pflanzer
3 mins read
The curious case of Remdesivir — the coronavirus ‘miracle drug’ may be overhyped, suggests Lancet study
Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases (NIAID)…
5 mins read
Trump's doctors are targeting a 'sweet spot' in fighting COVID-19 by using experimental treatments early, but physicians caution the data is limited
"We are clearly in a data-free zone right here," an infectious-disease physician told Business Insi…
Andrew Dunn
4 mins read
The federal government finally announced initial plans to distribute Gilead's coronavirus drug remdesivir after days of confusion
The government said it's distributing the promising coronavirus drug, remdesivir, to some hard-hit …
Anna Medaris Miller
2 mins read
Gilead tanks 9% on report its coronavirus drug doesn't help patients
The report contained "inappropriate characterizations," Gilead said, adding that low enrollment led…
Ben Winck
1 min read
2020 has been a rollercoaster ride for markets, with plenty of crashes, rallies, insolvencies, and stimulus packages. Here are the 15 top market moments so far.
Coronavirus sparked a chain reaction in global financial markets, and has become the dominant marke…
Saloni Sardana
3 mins read
The US bought up 90% of the world's supply of remdesivir for the next 3 months, and patents mean many countries won't be able to get any
Gilead Sciences will sell almost all of the world's supply of remdesivir to the US for the next thr…
Mia Jankowicz
2 mins read
Gilead sets a price for its coronavirus treatment — Pfizer's newest digital health bet — Reopenings reversed
These are the top stories written by Business Insider's healthcare team for June 30.
Lydia Ramsey Pflanzer
2 mins read
The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it's charging up to $520 a vial for remdesivir
Governments of developed countries will pay $2,340 for a five-day course of the antiviral drug remd…
Andrew Dunn
2 mins read
EXCLUSIVE: See the presentation Cedar used to convince investors like Andreessen Horowitz to invest $102 million
These are the top stories written by Business Insider's healthcare team for Tuesday, June 23.